Literature DB >> 21833601

Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells.

Lara Macchioni1, Magdalena Davidescu, Miriam Sciaccaluga, Cristina Marchetti, Graziella Migliorati, Stefano Coaccioli, Rita Roberti, Lanfranco Corazzi, Emilia Castigli.   

Abstract

Most cancer cells, including GL15 glioblastoma cells, rely on glycolysis for energy supply. The effect of antiglycolytic bromopyruvate on respiratory parameters and viability of GL15 cells was investigated. Bromopyruvate caused Δψ(m) and MTT collapse, ATP decrease, and cell viability loss without involving apoptotic or necrotic pathways. The autophagy marker LC3-II was increased. Δψ(m) decrease was accompanied by reactive oxygen species (ROS) increase and cytochrome c (cyt c) disappearance, suggesting a link between free radical generation and intramitochondrial cyt c degradation. Indeed, the free radical inducer menadione caused a decrease in cyt c that was reversed by N-acetylcysteine. Cyt c is tightly bound to the inner mitochondrial membrane in GL15 cells, which may confer protein peroxidase activity, resulting in auto-oxidation and protein targeting to degradation in the presence of ROS. This process is directed towards impairment of the apoptotic cyt c cascade, although cells are committed to die.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833601     DOI: 10.1007/s10863-011-9375-2

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  39 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  GL15 and U251 glioblastoma-derived human cell lines are peculiarly susceptible to induction of mitotic death by very low concentrations of okadaic acid.

Authors:  Emilia Castigli; Miriam Sciaccaluga; Gianluca Schiavoni; Flora Brozzi; Roberto Fabiani; Paolo Gorello; Gian Luigi Gianfranceschi
Journal:  Oncol Rep       Date:  2006-02       Impact factor: 3.906

3.  Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.

Authors:  Hong Jiang; Candelaria Gomez-Manzano; Hiroshi Aoki; Marta M Alonso; Seiji Kondo; Frank McCormick; Jing Xu; Yasuko Kondo; B Nebiyou Bekele; Howard Colman; Frederick F Lang; Juan Fueyo
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506

Review 4.  3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.

Authors:  S Ganapathy-Kanniappan; M Vali; R Kunjithapatham; M Buijs; L H Syed; P P Rao; S Ota; B K Kwak; R Loffroy; J F Geschwind
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

5.  Glycolysis as primary energy source in tumor cell chemotaxis.

Authors:  M E Beckner; M L Stracke; L A Liotta; E Schiffmann
Journal:  J Natl Cancer Inst       Date:  1990-12-05       Impact factor: 13.506

6.  Interleukin-1beta induces apoptosis in GL15 glioblastoma-derived human cell line.

Authors:  E Castigli; C Arcuri; L Giovagnoli; R Luciani; L Giovagnoli; T Secca; G L Gianfranceschi; V Bocchini
Journal:  Am J Physiol Cell Physiol       Date:  2000-12       Impact factor: 4.249

7.  Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors.

Authors:  Valerian E Kagan; Vladimir A Tyurin; Jianfei Jiang; Yulia Y Tyurina; Vladimir B Ritov; Andrew A Amoscato; Anatoly N Osipov; Natalia A Belikova; Alexandr A Kapralov; Vidisha Kini; Irina I Vlasova; Qing Zhao; Meimei Zou; Peter Di; Dimitry A Svistunenko; Igor V Kurnikov; Gregory G Borisenko
Journal:  Nat Chem Biol       Date:  2005-08-14       Impact factor: 15.040

8.  Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.

Authors:  Hideaki Ito; Hiroshi Aoki; Florian Kühnel; Yasuko Kondo; Stefan Kubicka; Thomas Wirth; Eiji Iwado; Arifumi Iwamaru; Keishi Fujiwara; Kenneth R Hess; Frederick F Lang; Raymond Sawaya; Seiji Kondo
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

9.  Generation of reactive oxygen species by the mitochondrial electron transport chain.

Authors:  Yuanbin Liu; Gary Fiskum; David Schubert
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

Review 10.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

View more
  15 in total

1.  Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells.

Authors:  Magdalena Davidescu; Miriam Sciaccaluga; Lara Macchioni; Roberto Angelini; Patrizia Lopalco; Maria Grazia Rambotti; Rita Roberti; Angela Corcelli; Emilia Castigli; Lanfranco Corazzi
Journal:  J Bioenerg Biomembr       Date:  2012-02-09       Impact factor: 2.945

2.  Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells.

Authors:  Filipa Lopes-Coelho; Carolina Nunes; Sofia Gouveia-Fernandes; Rita Rosas; Fernanda Silva; Paula Gameiro; Tânia Carvalho; Maria Gomes da Silva; José Cabeçadas; Sérgio Dias; Luís G Gonçalves; Jacinta Serpa
Journal:  Oncotarget       Date:  2017-08-16

Review 3.  3-Bromopyruvate: targets and outcomes.

Authors:  Maria C Shoshan
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

Review 4.  Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug.

Authors:  Simone Cardaci; Enrico Desideri; Maria Rosa Ciriolo
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

Review 5.  The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.

Authors:  Catherine J Libby; Anh Nhat Tran; Sarah E Scott; Corinne Griguer; Anita B Hjelmeland
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 10.680

Review 6.  The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.

Authors:  J Azevedo-Silva; O Queirós; F Baltazar; S Ułaszewski; A Goffeau; Y H Ko; P L Pedersen; A Preto; M Casal
Journal:  J Bioenerg Biomembr       Date:  2016-07-25       Impact factor: 2.945

7.  The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria.

Authors:  Lara Macchioni; Magdalena Davidescu; Rita Roberti; Lanfranco Corazzi
Journal:  J Bioenerg Biomembr       Date:  2014-09-07       Impact factor: 2.945

8.  Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells.

Authors:  Xiaohong Pan; Xiuli Zhang; Hongliu Sun; Jinjin Zhang; Miaomiao Yan; Huaibin Zhang
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

9.  Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells.

Authors:  Ana Sofia Rodrigues; Sandro L Pereira; Marcelo Correia; Andreia Gomes; Tânia Perestrelo; João Ramalho-Santos
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes.

Authors:  Magdalena Davidescu; Lara Macchioni; Gaetano Scaramozzino; Maria Cristina Marchetti; Graziella Migliorati; Rita Vitale; Angela Corcelli; Rita Roberti; Emilia Castigli; Lanfranco Corazzi
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.